Medicine News and Research

RSS

Researchers develop new type of drug to kill non-Hodgkin lymphoma tumor cells

Three researchers who are recipients of a collaborative grant from the Samuel Waxman Cancer Research Foundation have developed a new type of drug designed to kill non-Hodgkin lymphoma tumor cells. The breakthrough could lead to potential non-toxic therapies for cancer patients. The Foundation-funded investigators include Ari Melnick, M.D., of Weill Cornell Medical College, Alexander MacKerell, Ph.D., of the University of Maryland and Gilbert Priv-, Ph.D., of the University of Toronto.

11 May 2010

Can familiar voices heal traumatic brain injuries?

In January 2009, Ryan, a 21-year-old college student from Huntley, Ill., was in a coma after he had been flung from his snowmobile into a tree during an ice storm. He had a traumatic brain injury; the fibers of his brain had been twisted and stretched from the impact.

11 May 2010

UNC-CH awarded $100,000 Grand Challenges Explorations grant for study of ultrasound as a contraceptive

The University of North Carolina at Chapel Hill has received a $100,000 Grand Challenges Explorations grant from the Bill & Melinda Gates Foundation. The grant will support an innovative global health research project conducted by James Tsuruta, PhD, and Paul Dayton, PhD, titled "Ultrasound as a long-term, reversible contraceptive."

11 May 2010

Folic acid supplement may improve blood flow in young amenorrheic runners

A study led by sports medicine researcher Anne Hoch, D.O. at The Medical College of Wisconsin in Milwaukee has found that oral folic acid may provide a safe and inexpensive treatment to improve vascular function in young female runners who are amenorrheic (not menstruating).

11 May 2010

New findings could help develop vaccines against respiratory infections

Inducing cellular immunity as a means to protect against influenza virus is the focus of several laboratories at the Trudeau Institute. Researchers here have recently identified two important signaling components required by the immune system that might allow us to pre-position our own virus-fighting T cells to the lungs, the site of initial infection.

11 May 2010

Iris Biotechnologies receives two new Canadian patents

Iris BioTechnologies Inc., a life sciences company focused on providing patients, doctors, and clinicians with improved methods of identifying effective treatment solutions, and recipient of the Frost and Sullivan 2008 Technology Innovation Award in Pharmacogenomics, today announced two new Canadian patents.

11 May 2010

Free health clinics still drawing large crowds in cities across U.S.

Parade: A series of no-cost health care clinics are making their way across America. In Atlanta 1,050 volunteers gave their time to serve uninsured Americans who needed medical care. "The Atlanta mega-clinic was the sixth in a series that began in September. (The first was held in Houston in partnership with TV talk-show host and cardiothoracic surgeon Dr. Mehmet Oz.)

11 May 2010

BIOTX introduces Estrofil menopause supplements in North America

BIOTX Limited – a manufacturer and developer of dietary supplements based on Traditional Chinese Medicine, today launched Estrofil in North America - an all-natural nutritional menopause supplement for the relief of menopausal symptoms. This new menopause natural remedy is not estrogen or hormone replacement therapy.

10 May 2010

CHRISTUS Health selects Wolters Kluwer Health's ProVation Order Sets electronic solution

Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that CHRISTUS Health has selected ProVation® Order Sets, powered by UpToDate® Decision Support, as its electronic order set solution. In addition to automating development and maintenance, ProVation Order Sets will provide clinicians at 24 CHRISTUS facilities with point-of-care access to order sets and other intuitive clinical decision support tools.

10 May 2010

Harbor BioSciences reports encouraging results from Triolex Phase IIa trials

Harbor Biosciences, a biopharmaceutical company developing novel therapeutics for the treatment of cancer, metabolic and inflammatory diseases, today released an update to its development program for Triolex to treat obesity-induced insulin resistance and type-2 diabetes mellitus (T2DM).

10 May 2010

Asthmatx announces first U.S. patient treated with BT delivered by Alair System

Asthmatx, Inc. reported today that doctors at Virginia Hospital Center in Arlington, Va., recently treated the first U.S. patient with bronchial thermoplasty (BT) delivered by the Alair® System, the first device-based asthma treatment approved by the U.S. Food and Drug Administration (FDA).

10 May 2010

Medical options to help prostate cancer patients make informed treatment decisions

While the dreaded words "You have prostate cancer" often leave patients confused, the impact of the diagnosis can extend to the entire family, especially wives, says a top expert.

10 May 2010

UC San Diego researchers discover potential new treatment for familial adenomatous polyposis

A team of University of California, San Diego School of Medicine researchers has discovered that common intestinal bacteria appear to promote tumor growths in genetically susceptible mice, but that tumorigenesis can be suppressed if the mice are exposed to an inhibiting protein enzyme.

10 May 2010

Positive results from Cytori's Celution-based ADRC trial for treatment of no-option chronic heart disease patients

The first clinical trial of adipose (fat) tissue-derived stem and regenerative cells (ADRCs) for the treatment of no-option chronic heart disease patients showed the following: the procedure was safe and feasible; it demonstrated a statistically significant improvement in maximum oxygen consumption and patients' aerobic capacity measured as metabolic equivalents

10 May 2010

Majority of Americans concerned about skin cancer but still like tans

When it comes to tanning, dermatologists have long suspected that most people need an attitude adjustment. Now, results of a new survey by the American Academy of Dermatology (Academy) confirmed that the majority of people still idolize the bronzed look of a tan despite wanting to protect themselves from skin cancer.

10 May 2010

Zilver PTX Drug-Eluting Peripheral Stent safe and effective for treating SFA lesions

Patients treated with the Zilver® PTX™ Drug-Eluting Peripheral Stent maintained clinical improvement at two years, according to interim results from the Zilver® PTX™ Global Registry presented today as a late-breaking clinical trial at the Society for Cardiovascular Angiography and Interventions (SCAI) 33rd Annual Scientific Sessions.

10 May 2010

Everolimus-eluting stents more effective than paclitaxel-eluting stents

Results from the SPIRIT IV clinical trial, which were first presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2009 scientific symposium, were published today in the New England Journal of Medicine.

10 May 2010

Experts to present latest research on prostate cancer and related conditions

WHAT: This symposium features a renowned faculty of clinicians and researchers who will present leading-edge information on the best standards of care in managing the full spectrum of prostate cancer and related conditions.

10 May 2010

Majority of people like suntan but concerned about skin cancer

10 May 2010

Steroids can raise cardiovascular risks in post-transplant patients

Post-transplant patients who have been removed from a corticosteroid regimen have fewer cardiovascular events than those patients on steroids, increasing their graft survival rates and reducing early mortality, according to study results being presented this week by University of Cincinnati (UC) transplantation researchers.

10 May 2010

Medicine News and Research

Researchers develop new type of drug to kill non-Hodgkin lymphoma tumor cells

Can familiar voices heal traumatic brain injuries?

UNC-CH awarded $100,000 Grand Challenges Explorations grant for study of ultrasound as a contraceptive

Folic acid supplement may improve blood flow in young amenorrheic runners

New findings could help develop vaccines against respiratory infections

Iris Biotechnologies receives two new Canadian patents

Free health clinics still drawing large crowds in cities across U.S.

BIOTX introduces Estrofil menopause supplements in North America

CHRISTUS Health selects Wolters Kluwer Health's ProVation Order Sets electronic solution

Harbor BioSciences reports encouraging results from Triolex Phase IIa trials

Asthmatx announces first U.S. patient treated with BT delivered by Alair System

Medical options to help prostate cancer patients make informed treatment decisions

UC San Diego researchers discover potential new treatment for familial adenomatous polyposis

Positive results from Cytori's Celution-based ADRC trial for treatment of no-option chronic heart disease patients

Majority of Americans concerned about skin cancer but still like tans

Zilver PTX Drug-Eluting Peripheral Stent safe and effective for treating SFA lesions

Everolimus-eluting stents more effective than paclitaxel-eluting stents

Experts to present latest research on prostate cancer and related conditions

Majority of people like suntan but concerned about skin cancer

Steroids can raise cardiovascular risks in post-transplant patients

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News